Abstracts tagged "Gout and rheumatoid arthritis (RA)"

Abstract Number: 234 • 2016 ACR/ARHP Annual Meeting
Coexistent Gout and Rheumatoid Arthritis: Comparison of Comorbidity, Autoantibodies, Disease Measures, and All-Cause Mortality
Bryant R. England^1,2, Tina D. Mahajan³, Namrata Singh⁴, Brian W Coburn³, Grant W. Cannon⁵, Gail S. Kerr⁶, Andreas Reimold⁷, Angelo L. Gaffo⁸ and Ted R Mikuls⁹, ¹Division of Rheumatology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, ²VA Nebraska-Western Iowa, Omaha, NE, ³Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE, ⁴Internal Medicine, University of Iowa Hospitals and Clinics and Iowa City VA, Iowa City, IA, ⁵Internal Medicine, Veterans Affairs Salt Lake City Health Care System and University of Utah School of Medicine, Salt Lake City, UT, ⁶Washington DC VAMC, Georgetown University Hospital, Howard University Hospital, Washington, DC, ⁷Dallas VA Medical Center and University of Texas Southwestern Medical Center, Dallas, TX, ⁸Birmingham VA & University of Alabama at Birmingham, Birmingham, AL, ⁹Veteran Affairs Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, NE
Background/Purpose: Coexistent RA and gout were previously believed to be exceedingly rare due to several hypothesized mechanisms encompassing inhibition of crystal formation, deposition, and activation.…
Abstract Number: 2048 • 2015 ACR/ARHP Annual Meeting
Hospitalization Trends of Rheumatoid Arthritis and Gout in the United States: A Crossroad
Sian Yik Lim¹, Na Lu¹, Mark Fisher¹, Amar Oza¹, Sharan K. Rai², Mariano E Menendez¹ and Hyon Choi¹, ¹Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ²Experimental Medicine, University of British Columbia, Vancouver, BC, Canada
Background/Purpose: Rheumatoid arthritis (RA) and gout are the two most common inflammatory arthritides in the US and beyond. As hospitalization for these conditions are known…
Abstract Number: 134 • 2012 ACR/ARHP Annual Meeting
Co-Existence of Gout in Rheumatoid Arthritis: It Does Happen! A Population Based Study
Adlene Jebakumar¹, Cynthia S. Crowson², P. Deepak Udayakumar¹ and Eric L. Matteson¹, ¹Rheumatology, Mayo Clinic, Rochester, MN, ²Department of Health Sciences Research, Mayo Clinic, Rochester, MN
Background/Purpose: Even though there are a few cases in the literature reporting co-existence of gout and rheumatoid arthritis (RA), it has been a long time…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].